News

VulcanForms Secures $220 Million to Expand Metal Manufacturing

VulcanForms Secures $220 Million to Expand Metal Manufacturing

VulcanForms Secures Significant Financing for Expansion

Series D round led by Eclipse and 1789 Capital accelerates capacity expansion and strengthens domestic industrial resilience

VulcanForms, the pioneer of a fully integrated digital metal manufacturing platform in the U.S., has successfully closed an impressive $220 million financing round. This round, spearheaded by Eclipse and 1789 Capital, is backed by notable investments from Washington Harbour, Fontinalis, IEQ Capital, and other partners. This funding comes in response to an increasing demand for secure and reliable domestic manufacturing capabilities for advanced metal products, positioning VulcanForms as a key player in bolstering America’s advanced manufacturing sector.

The current landscape of metal manufacturing operates within a fragmented supply chain, relying on numerous vendors, facilities, and geographic locations. This disjointed system often leads to inflated costs, excess waste, and prolonged timelines with each handoff. As global geopolitical challenges and shifts in industrial policy continue to reshape the manufacturing world, this conventional model has become less effective and hard to scale. VulcanForms addresses these inefficiencies by integrating complex, multi-step supply chains into advanced, domestic digital factories designed specifically for scalable, production-grade manufacturing.

The fresh capital infusion will enhance VulcanForms' manufacturing capabilities through expanding their fully integrated facilities, which combine cutting-edge metal additive manufacturing technologies, precise machining, automation, inspection, and proprietary AI-driven software into a seamless end-to-end workflow. By streamlining the supply chain into a unified production system, VulcanForms aims to cut down on complexity and waste, ultimately lowering overall system costs while consistently delivering high-performance products at scale.

Proven Adoption Across Critical Sectors

VulcanForms has transitioned effectively from the development stage into industrial-scale production and has secured substantial multi-billion dollar commercial programs across a variety of sectors, including medical devices, aerospace, defense, and consumer products. These successful engagements testify to VulcanForms' capacity to produce high-quality metal products at large volumes, illustrating a broader trend where organizations are choosing to relocate critical manufacturing operations back to American shores, especially when a reliable and efficient supplier option is available.

"American manufacturers need domestic alternatives capable of competing with global production on a large scale while ensuring superior speed and precision," emphasized Kevin Kassekert, CEO of VulcanForms. "This financing empowers us to address the rising demand and enhance our role as a pivotal partner for companies reconstructing robust domestic supply chains."

The fully integrated digital metal manufacturing platform created by VulcanForms merges cutting-edge approaches and technologies into a cohesive workflow. This integration not only improves quality and consistency but also enhances lead-time predictability while significantly bolstering domestic sourcing for essential components. As industries ranging from aerospace to healthcare strive to diminish their reliance on foreign suppliers and hasten innovation cycles, VulcanForms is equipping the U.S. with the necessary industrial strength for the future of manufacturing.

"1789 Capital is excited to support VulcanForms, a transformative company committed to revitalizing America's industrial capabilities and greatly reducing our dependency on external suppliers," remarked Omeed Malik, President of 1789 Capital. "By bringing high-skilled manufacturing jobs back to the U.S., VulcanForms contributes to the next great chapter of American prosperity."

"To restore America’s industrial capacity, we need bold engineering and the capability to scale manufacturing, and VulcanForms has demonstrated its proficiency in both," stated Greg Reichow, Partner at Eclipse. "Their platform is crucial for relocating the production of essential components back onshore with unparalleled precision and reliability. Eclipse takes pride in supporting a team that is not only producing remarkable industrial output today but also shaping the future of U.S. manufacturing."

About VulcanForms

VulcanForms is at the forefront of developing advanced digital metal manufacturing technology and is deploying integrated production facilities within the United States. Their facilities merge metal additive manufacturing, precision machining, automation, inspection, and proprietary software into one comprehensive platform. By integrating technology and manufacturing vertically, VulcanForms empowers American companies to create intricate, high-performance metal components at scale, maintaining quality and secure supply chains that are economically viable.

Frequently Asked Questions

What is the purpose of the $220 million financing VulcanForms secured?

The financing aims to expand VulcanForms' integrated manufacturing capabilities and consolidate domestic metal production.

Who are the lead investors in VulcanForms' Series D round?

The financing round was led by Eclipse and 1789 Capital, with other notable participants.

What sectors is VulcanForms focusing on for its expansions?

VulcanForms is targeting sectors including aerospace, medical devices, defense, and industrial products.

How does VulcanForms plan to streamline manufacturing?

By integrating multi-step supply chains into a single digital platform, VulcanForms aims to reduce waste and lower costs.

What impact does VulcanForms hope to have on American manufacturing?

VulcanForms aims to enhance domestic production capabilities, reduce reliance on foreign suppliers, and create high-skilled jobs in the U.S.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 20

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 21

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading